Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Gastrointestinal 5Breast 4Thoracic 3Tumor-Agnostic 1Other 1Lymphoid 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 400Radiotherapy 238Bevacizumab 184Magnetic Resonance Spectroscopy 167Radiosurgery 141Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 75pembrolizumab 69Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Ipilimumab 36Lomustine 35Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vitamin E × CNS × Clear all
NCT01508221 2023-09-14

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

University of Cincinnati

Phase 2 Completed
31 enrolled 8 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡